Lion Biotechnologies to Present at the Biotech Showcase on January 15
13 January 2014 - 1:00PM
Business Wire
Lion Biotechnologies, Inc. (OTCQB: LBIO) announced that Chief
Executive Officer Manish Singh, Ph.D., will present at the Biotech
Showcase on Wednesday, January 15, 2014, at 11:00 a.m. Pacific. The
conference is being held at the Parc 55 Wyndham Union Square Hotel
in San Francisco. Dr. Singh’s presentation will be in Mission Room
II.
Now in its sixth year, Biotech Showcase is an investor and
partnering conference devoted to providing private and public
biotechnology and life sciences companies with an opportunity to
present to, and meet with, investors and pharmaceutical executives
in one place. This rapidly growing conference features multiple
tracks of presenting companies, plenary sessions, workshops,
networking, and an opportunity to schedule one-to-one meetings.
A live webcast of the presentation will be accessible online on
at www.lionbio.com. An archived version will be available for 90
days following the event.
About Lion Biotechnologies
Lion Biotechnologies, Inc. is engaged in the development of
T-cells and engineered T-cells for the treatment of various
cancers. The company's lead product candidate is a ready-to-infuse
autologous T-cell therapy utilizing tumor-infiltrating lymphocytes
(TILs) for the treatment of patients with Stage IV metastatic
melanoma, and is based on a clinical CRADA with the National Cancer
Institute along with physician-sponsored investigational therapy at
the MD Anderson Cancer Center and the H. Lee Moffitt Cancer &
Research Institute. For more information, please visit
http://www.lionbio.com.
INVESTOR CONTACT:LHADon MarkleySenior Vice
President310-691-7100dmarkley@lhai.com